Novartis drug Zortress® is first in over a decade approved by FDA to prevent organ rejection in adult liver transplant patients »

[at noodls] – Zortress is the first mTOR inhibitor approved to prevent organ rejection in adult liver transplant patients in the US, where it is already approved for kidney transplantation Approval based on positive … more

View todays social media effects on NVS

View the latest stocks trending across Twitter. Click to view dashboard

See who Novartis is hiring next, click here to view